Matsuura et al have shown that PTX3 is more enhanced in vulnerable plaques than stable plaques in coronary artery of patients with angina pectoris and immunoreactivity for PTX3 is intense in the areas with intraplaque hemorrhage [38]. This evidence concerns the gene PTX3 and angina pectoris.